Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The study will describe how mavacamten is used in routine care for Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), including use as monotherapy or with other background/concomitant oHCM medications.
Epistemonikos ID: 965c5fafe58c1e075d1c7586b75c498a61b3d6ba
First added on: Sep 30, 2026